Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.1% |
| 2 | Technology | 1.55% |
| 3 | Consumer Discretionary | 0.95% |
| 4 | Financials | 0.77% |
| 5 | Healthcare | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AOMR
11076
Angel Oak Mortgage REIT
AOMR
$194M
| $176K | ﹤0.01% |
+18,468
| New | +$184K |
|
11077
PUT
Genworth Financial
GNW
$3.77B
| $176K | ﹤0.01% |
24,800
-25,700
| -51% | -$179K |
|
11078
Proshares UltraShort Technology
REW
$3.51M
| $175K | ﹤0.01% |
3,522
-6,468
| -65% | -$276K |
|
|
FTF
11079
Franklin Limited Duration Income Trust
FTF
$234M
| $175K | ﹤0.01% |
27,137
+6,442
| +31% | +$42.4K |
|
11080
CALL
Ranpak Holdings
PACK
$420M
| $175K | ﹤0.01% |
+32,300
| New | +$212K |
|
11081
CALL
Sana Biotechnology
SANA
$1.18B
| $175K | ﹤0.01% |
104,200
-174,700
| -63% | -$488K |
|
|
HTZWW
11082
Hertz Global Holdings Warrants
HTZWW
$86M
| $175K | ﹤0.01% |
77,245
| – | – |
|
11083
CALL
Emergent Biosolutions
EBS
$303M
| $174K | ﹤0.01% |
35,900
-132,900
| -79% | -$1.1M |
|
|
RAYC
11084
DELISTED
Rayliant Quantamental China Equity ETF
RAYC
| $174K | ﹤0.01% |
12,092
-55,950
| -82% | -$797K |
|
11085
CALL
Editas Medicine
EDIT
$485M
| $174K | ﹤0.01% |
150,100
+115,500
| +334% | +$170K |
|
11086
Lexeo Therapeutics
LXEO
$399M
| $174K | ﹤0.01% |
50,147
+38,999
| +350% | +$173K |
|
11087
MediWound
MDWD
$163M
| $174K | ﹤0.01% |
11,208
-5,209
| -32% | -$93.2K |
|
11088
CALL
Biomea Fusion
BMEA
$125M
| $173K | ﹤0.01% |
81,400
-535,300
| -87% | -$1.82M |
|
11089
CALL
Sypris Solutions
SYPR
$40.1M
| $173K | ﹤0.01% |
107,600
+11,600
| +12% | +$22.5K |
|
11090
AdvisorShares Dorsey Wright Short ETF
DWSH
$5.95M
| $173K | ﹤0.01% |
23,036
+5,354
| +30% | +$38.1K |
|
|
CEPU
11091
PUT
Central Puerto
CEPU
$2.01B
| $173K | ﹤0.01% |
+15,600
| New | +$206K |
|
11092
CALL
Thryv Holdings
THRY
$84.4M
| $173K | ﹤0.01% |
+13,500
| New | +$224K |
|
11093
Wendy's
WEN
$1.58B
| $173K | ﹤0.01% |
11,816
-7,654
| -39% | -$115K |
|
|
SFIX
11094
CALL
Stitch Fix
SFIX
$420M
| $173K | ﹤0.01% |
53,100
-212,700
| -80% | -$969K |
|
11095
PUT
Mitek Systems
MITK
$851M
| $172K | ﹤0.01% |
20,900
-7,500
| -26% | -$72.9K |
|
11096
CALL
Certara
CERT
$1.27B
| $172K | ﹤0.01% |
17,400
+5,900
| +51% | +$71.7K |
|
11097
Actinium Pharmaceuticals
ATNM
$31.7M
| $172K | ﹤0.01% |
106,982
+75,043
| +235% | +$95.3K |
|
11098
CALL
Getty Images
GETY
$107M
| $172K | ﹤0.01% |
99,500
-46,700
| -32% | -$111K |
|
|
BRDG
11099
DELISTED
Bridge Investment Group
BRDG
| $172K | ﹤0.01% |
+17,966
| New | +$157K |
|
11100
Global X NASDAQ 100 Risk Managed Income ETF
QRMI
$14.4M
| $172K | ﹤0.01% |
10,318
-24,197
| -70% | -$417K |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q1 2025 filing shows 1,775 new, 5,712 increased, 4,842 reduced and 1,482 closed positions. Its largest new stake was Brookfield Asset Management: 1,775,684 shares worth $86M. The largest sale was Invesco QQQ Trust, an estimated $1.25B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.